glp-1 tn Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response based formulation is particularly appealing GLP-1 Injections for Weight Loss

Again, tirzepatide appears to be more potent, generating average losses of approximately 20% at the highest doses (10 and 15 mg/week) administered for 72 weeks (Figure 5B)

However, the authors emphasize the need for longer-term studies and trials focused specifically on individuals with binge eating disorder to better understand the full benefits and potential risks of these medications

10 ways to prevent or lessen GLP-1 side effects Who should avoid or use caution with GLP-1s

At MDWatch, compounded Tirzepatide is dispensed by licensed U.S

PMID: 8138058

Other studies show that weight regain after GLP-1 use is common (2